Skip to main content

Table 2 Proportion of patients with low disease activity according to DAS28-ESR cutoff at week 52 without post-flare censoring

From: Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis

Patient group ETN (N = 22) PBO (N = 29)
Overall 16/22 (72.7%) 23/29 (79.3%)
Did not flare 9/9 (100%) 8/8 (100%)
Did flarea 7/13 (53.8%) 15/21 (71.4%)
  1. LDA Low disease activity
  2. aAll patients who experienced a flare were administered etanercept rescue treatment